TY  - JOUR 
T1  - Monoclonal antibodies against beta-amyloid protein (lecanemab and donanemab) should not be used in the treatment of Alzheimer's disease
JO  - Arquivos de Neuro-Psiquiatria
A1  - Nitrini, Ricardo
A1  - Studart-Neto, Adalberto
SN  - 0004-282X
UL  - 10.1055/s-0045-1808082
VL  - 83 
Y1  - 2025
PB  - Brasil 
ER  -